Nutramax cough/cold sales up 47% in second quarter; PFI third quarter sales jump 56.7%.
This article was originally published in The Tan Sheet
Executive Summary
NUTRAMAX COUGH/COLD SALES UP 47% TO $7.8 MIL. IN THE SECOND QUARTER ended March 29, the Gloucester, Mass.-based com-pany reported. The category comprised about 31% of the company's overall second quarter sales. The company noted that it had a "superb" cough/cold season; cough drop sales are "strong," Nutramax said, and contract manufacturing for the category (Celestial Seasonings and Whitehall's Robitussin) has been "increasing radically and dramatically."